Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 33, 1998 - Issue 8
Submit an article Journal homepage
149
Views
164
CrossRef citations to date
0
Altmetric
Research Article

Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in Pigs

M. WØJDEMANN, A. WETTERGREN, B. HARTMANN, J. J. HOLST
Pages 828-832 | Published online: 08 Jul 2009

References

  • Bell GI, Santerre RF, Mullenbach GT. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 1983;302:716–8.
  • Mojsov S, Heinrich G, Wilson IB, Ravazola M, Orci L, Habener JF. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 1986;261:11880–9.
  • Ørskov C, Holst JJ, Knuthsen S, Baldissera FGA, Poulsen SS, Nielsen OV. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from the pig small intestine, but not the pancreas. Endocrinology 1986;119: 1467–75.
  • Buhl T, Thim L, Kofod H, Ørskov C, Harling H, Holst JJ. Naturally occurring products of proglucagon 111–160 in the porcine and small intestine. J Biol Chem 1988;263: 8621–4.
  • Holst JJ. Enteroglucagon. Ann Rev Physiol 1997;59:257–71.
  • Wettergren A, Schjoldager BGT, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78–107 amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993;38:665–73.
  • Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1: association with inhibition of gastric acid in humans. Dig Dis Sci 1993;40:1074–82.
  • Layer P, Franke A, Holst JJ, Grandt D, Goebell H. Glucagonlike peptide-1 inhibits pancreatic enzyme secretion in humans. Gastroenterology 1996;110:F1409.
  • Holst JJ, Ørskov C, Hartmann B, Deacon CF. Posttranslational processing of proglucagon and postsecretory fate of proglucagon products. The insulinotropic gut hormone glucagon-like-peptide-1. Front Diabetes 1997;13:24–48.
  • Schmidt WE, Siegel EG, Creutzfeldt W. Effect of glucagon-like peptide-1 on insulin secretion. Diabetologia 1985;28: 704–7.
  • Drucker DJ, Ehrlich P, Asa L, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like-peptide-2. Proc Natl Acad Sci USA 1996;93:7911–6.
  • Holst JJ, Wettergren A, Wøjdemann M, Poulsen SS, Ørskov C. Glucagon-like peptide-1 (GLP-1) an important enterogastrone acting via the central nervous system. Hepatogastroenterol 1995;42: 1071.
  • Holst JJ, Bersani M. Assays for peptide products of somatostatin gene expression. In: Methods in neurosciences. New York: Academic Press, Inc.; 1991.
  • Hilsted L, Holst JJ. On the accuracy of radioimmunological determination of somatostatin in plasma. Regul Pept 1982;4:13–31.
  • Bell GI, Sanchez-Pescador R, Layborn PJ, Najarian RC. Exon duplication and divergence in the human glucagon gene. Nature 1983;304:368–71.
  • Hartmann B, Johnsen AH, Ørskov C, Holst JJ. Structure, analysis and secretion of human glucagon-like peptide-2 (GLP-2). Diabetes 1996;45: Suppl 2:300A.
  • Shimizu I, Hirota M, Oboshi C, Shima K. Effect of glucagonlike peptide-1 and 2 on glycogenolysis in cultured rat hepatocytes. Biomed Res 1986;7:431–6.
  • Irwin DM, Wong J. Trout and chicken proglucagon: alternative splicing generates mRNA transcripts encoding glucagon-like peptide-2. Mol Endocrinol 1995;9:267–77.
  • Lund PK, Hoyt E, Simmons JG, Ulshen MH. Regulation of intestinal glucagon gene expression during adaptive growth of small intestine. Digestion 1993;54:371–2.
  • Tsai CH, Hill M, Drucker DJ. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol 1997;272:G662–8.
  • Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 1997;273:E77–84.
  • Bloom sR. Gut hormones in adaption. Gut 1987;28: Suppl 1:315.
  • Nauck MA, Niederreichholz U, Ettler U, Holst JJ, Ørskov C, Ritzel R, et al. Glucacon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 1997;273(5 Pt 1):E981–8.
  • Miller RE, Chernish SM. The response of gastrointestinal tract motility to glucagon. In: Picazo J, editor. Glucagon in gastroenterology and hepatology. Lancaster, UK: MTP Press; 1982. p. 37–54.
  • Wen J, Phillips SF, Sarr MG, Kost LJ, Holst JJ. PYY and GLP-1 contribute to feed-back inhibtion from the canine ileum and colon. Am J Physiol 1995;269:G945–52.
  • Flint A, Raben A, Holst JJ, Astrup A. Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans [abstract]. Int J Obes 1997;21 Suppl 2:28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.